(Q34611697)

3 August 2017

1 reference

title

Safety of newer antidepressants in pregnancy (English)

1 reference

3 August 2017

Cynthia M Way

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

546-552

1 reference

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Outcomes of prenatal antidepressant exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Birth outcomes after prenatal exposure to antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Risks associated with selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Antidepressant drugs during pregnancy and infant congenital heart defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

The impact of depression and fluoxetine treatment on obstetrical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Neurodevelopment of children exposed in utero to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Newer antidepressants in pregnancy: prospective outcome of a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

Pharmacotherapy for smoking cessation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.546

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.4.546

1 reference

3 August 2017

1 reference